Clinical Trials Unit
Stanford University School of Medicine's Center for Advanced Dermatologic Investigation is the Dermatology Department's clinical trials unit.
The Center is home to 12-15 ongoing clinical studies, investigating the safety and efficacy of new and currently available drugs and over-the-counter medications. The Center works with Stanford's own panel on medical research, leading pharmaceutical companies,and the Food and Drug Administration to safely and ethically expand the medical field's knowledge of dermatologic treatments. New studies begin regularly, and the Center continues to recruit patients with skin aging, sun damage, skin cancer (including basal cell carcinomas), psoriasis, atopic dermatitis, rosacea, and other dermatologic diseases for ongoing studies.
Skin Aging Studies
We seek to understand the human aging processes as it relates to skin on a fundamental level. To this end, our studies focus on clinical and translational research efforts ranging from: (1) the analysis of gene changes which predispose individuals to exceptionally youthful skin to (2) molecular signatures that may be biomarkers for aging skin to (3) the careful study of new candidate agents which might affect the skin aging process.
Nonmelanoma Skin Cancer
Recent advances in our understanding of basal cell skin cancer biology have enabled the development of cutting edge study drugs which combat tumor growth. We are currently home to a number of clinical trials at the forefront of potential therapy for advanced or metastatic basal cell cancer. In addition, we seek to understand the biology of basal cell skin cancers and to identify molecular predictors for treatment success.
Acne Rosecea
This is a common and frustrating chronic inflammatory condition of the face, usually affecting older individuals. The causes of this complex condition are the subject of much study. Our clinical studies seek to identify new topical or oral medications to improve the symptoms of acne rosacea.
Contact
For more information, please email dermtrials@stanford.edu
Featured Clinical Trials
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested
Psoriasis Clinical Trials
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested
Dermatology Clinical Trials
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested
Pediatric Dermatology Clinical Trials
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested
Immunophenotyping Assessment in a COVID-19 Cohort
This surveillance study will collect detailed clinical, laboratory, and radiographic data in coordination with biologic sampling of blood and respiratory secretions and viral shedding in nasal secretions in order to identify immunophenotypic and genomic features of COVID-19 -related susceptibility and/or progression. The aim: for the results obtained from this study to assist in generating hypotheses for effective host-directed therapeutic interventions, to help to prioritize proposals for such interventions, and/or optimize timing for administration of host-response directed therapeutics.
Stanford is currently accepting patients for this trial.
Intervention(s):
- procedure: Biological sample collection
- procedure: Data Collection: Clinical Care Assessments
Eligibility
Inclusion Criteria:
Individuals who meet all of the following criteria are eligible for enrollment as study
participants:
- Participant and/or surrogate understands the data to be collected and the study
procedures and is willing to participate in the surveillance cohort as described in
the study information sheet;
- ≥ 18 years of age at the time of hospitalization; and
- Admitted to a hospital with presumptive or documented coronavirus disease 2019
(COVID-19), with confirmation of Severe Acute Respiratory Syndrome Coronavirus-2
(SARS-CoV-2) infection by Polymerase Chain Reaction (PCR).
Exclusion Criteria:
Individuals who meet any of these criteria are not eligible for enrollment as study
participants:
- Underlying medical problems which, in the opinion of the investigator may be
associated with mortality unrelated to COVID-19 within 48 hours of hospitalization, or
a decision by the patient or surrogate prior to hospitalization to limit care to
comfort measures; or
- Medical problems or conditions such as pregnancy which might impact interpretation of
the immunologic data obtained.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Hena Din, MPH
650-724-7253
I'm interested